Vishal Sikri

Vishal Sikri currently serves as the President of the Advanced Diagnostics Division at NeoGenomics Laboratories since May 2022, having previously held leadership roles including President of Pharma Services at NeoGenomics and President and Chief Commercial Officer at Inivata. Prior experience includes President of Oncology at Invitae, US General Manager at Biocartis, and VP of Commercial Operations at Sysmex Inostics, where significant accomplishments include establishing commercial functions across teams and developing growth strategies. Early career roles involved management of product portfolios at Abbott Laboratories and marketing roles within Sysmex. Vishal Sikri holds an MBA from the Quinlan School of Business, Loyola University Chicago, an M.S. in Pharmaceutical Sciences from the University of Wisconsin-Madison, and a B.S. in Molecular Biology from Beloit College.